Gregory Crimmins

461 total citations
10 papers, 367 citations indexed

About

Gregory Crimmins is a scholar working on Genetics, Food Science and Molecular Biology. According to data from OpenAlex, Gregory Crimmins has authored 10 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Food Science and 2 papers in Molecular Biology. Recurrent topics in Gregory Crimmins's work include Yersinia bacterium, plague, ectoparasites research (4 papers), Salmonella and Campylobacter epidemiology (3 papers) and Vibrio bacteria research studies (2 papers). Gregory Crimmins is often cited by papers focused on Yersinia bacterium, plague, ectoparasites research (4 papers), Salmonella and Campylobacter epidemiology (3 papers) and Vibrio bacteria research studies (2 papers). Gregory Crimmins collaborates with scholars based in United States, Germany and Russia. Gregory Crimmins's co-authors include Daniel A. Portnoy, Nicole Meyer-Morse, Sridharan Raghavan, Jess H. Leber, Jeffery S. Cox, Anat A. Herskovits, Thomas W. Dubensky, Ralph R. Isberg, Peter Lauer and Joan Mecsas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Gregory Crimmins

8 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Crimmins United States 7 174 115 68 67 65 10 367
RP Darveau United States 6 147 0.8× 115 1.0× 38 0.6× 63 0.9× 29 0.4× 10 376
Susanne zur Lage Germany 9 64 0.4× 120 1.0× 63 0.9× 48 0.7× 93 1.4× 13 287
Shahid A. Khan United Kingdom 7 100 0.6× 67 0.6× 62 0.9× 56 0.8× 79 1.2× 7 299
Marielena Mata United States 6 164 0.9× 86 0.7× 103 1.5× 29 0.4× 35 0.5× 6 384
Ricardo Calderón-González Spain 13 169 1.0× 154 1.3× 97 1.4× 14 0.2× 57 0.9× 23 382
Jennifer Schär Germany 7 78 0.4× 185 1.6× 121 1.8× 53 0.8× 44 0.7× 7 477
T. Tosi France 13 121 0.7× 261 2.3× 31 0.5× 183 2.7× 69 1.1× 18 560
Sophie Palmer United Kingdom 9 292 1.7× 124 1.1× 24 0.4× 38 0.6× 116 1.8× 12 580
Gerd Lipowsky Latvia 8 109 0.6× 171 1.5× 24 0.4× 23 0.3× 92 1.4× 8 424
Joshua M. Royal United States 6 82 0.5× 122 1.1× 81 1.2× 30 0.4× 74 1.1× 11 282

Countries citing papers authored by Gregory Crimmins

Since Specialization
Citations

This map shows the geographic impact of Gregory Crimmins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Crimmins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Crimmins more than expected).

Fields of papers citing papers by Gregory Crimmins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Crimmins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Crimmins. The network helps show where Gregory Crimmins may publish in the future.

Co-authorship network of co-authors of Gregory Crimmins

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Crimmins. A scholar is included among the top collaborators of Gregory Crimmins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Crimmins. Gregory Crimmins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Crimmins, Gregory, et al.. (2024). Synergistic effects of RPT1G, a first-in-class small molecule NAMPT inhibitor, with venetoclax and olaparib in hematological malignancies.. Journal of Clinical Oncology. 42(16_suppl). e18512–e18512.
2.
Crimmins, Gregory, et al.. (2023). RPT1G: A 1 st-in-Class Small Molecule NAMPT Inhibitor As a Novel Therapeutic for Acute Lymphocytic Leukemia. Blood. 142(Supplement 1). 419–419.
3.
González-Juarbe, Norberto, Gregory Crimmins, Molly A. Bergman, et al.. (2016). CD8 + T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity. Infection Genetics and Evolution. 43. 289–296. 3 indexed citations
4.
5.
Crimmins, Gregory, et al.. (2012). Identification of MrtAB, an ABC Transporter Specifically Required for Yersinia pseudotuberculosis to Colonize the Mesenteric Lymph Nodes. PLoS Pathogens. 8(8). e1002828–e1002828. 45 indexed citations
6.
Crimmins, Gregory & Ralph R. Isberg. (2011). Analyzing microbial disease at high resolution: following the fate of the bacterium during infection. Current Opinion in Microbiology. 15(1). 23–27. 9 indexed citations
7.
Crimmins, Gregory, Michael W. Schelle, Anat A. Herskovits, et al.. (2009). Listeria monocytogenes 6-Phosphogluconolactonase Mutants Induce Increased Activation of a Host Cytosolic Surveillance Pathway. Infection and Immunity. 77(7). 3014–3022. 15 indexed citations
8.
Crimmins, Gregory, Anat A. Herskovits, Kai Rehder, et al.. (2008). Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proceedings of the National Academy of Sciences. 105(29). 10191–10196. 86 indexed citations
9.
Leber, Jess H., Gregory Crimmins, Sridharan Raghavan, et al.. (2008). Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen. PLoS Pathogens. 4(1). e6–e6. 176 indexed citations
10.
Wolfe, Adam D., Gregory Crimmins, Jo Ann Cameron, & Jonathan J. Henry. (2004). Early regeneration genes: Building a molecular profile for shared expression in cornea–lens transdifferentiation and hindlimb regeneration in Xenopus laevis. Developmental Dynamics. 230(4). 615–629. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by RP Darveau Breakdown of academic impact, for papers by Susanne zur Lage Breakdown of academic impact, for papers by Shahid A. Khan Breakdown of academic impact, for papers by Marielena Mata Breakdown of academic impact, for papers by Ricardo Calderón-González Breakdown of academic impact, for papers by Jennifer Schär Breakdown of academic impact, for papers by T. Tosi Breakdown of academic impact, for papers by Sophie Palmer Breakdown of academic impact, for papers by Gerd Lipowsky Breakdown of academic impact, for papers by Joshua M. Royal
Rankless by CCL
2026